Bristol-Myers Squibb return on equity (ROE)What is return on equity (ROE)? Return on equity (ROE) is a year of net income divided by shareholders' equity: the profit a company makes on each dollar its owners have in it.
Bristol-Myers Squibb's return on equity is 39.48%: net income of 9.24B USD over the last twelve months on shareholders' equity of 23.40B USD.
- Today
- 39.48%
- Average, 5 years
- 14.02%
- Low, 5 years
- -54.69%
- High, 5 years
- 41.55%
ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 9.24B ÷ 23.40B = 39.48%
Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.
Why is Bristol-Myers Squibb's return on equity so high?What is DuPont analysis? DuPont analysis splits return on equity into three parts: profit margin, asset turnover and the equity multiplier. It shows whether a high ROE comes from profits, from using assets well, or from debt.
- FY202514.6% × 0.54 × 4.87 = 38.2%
- FY2024-18.5% × 0.52 × 5.67 = -54.8%
- FY202317.8% × 0.47 × 3.23 = 27.3%
- FY202213.7% × 0.48 × 3.12 = 20.4%
- FY202115.1% × 0.42 × 3.04 = 19.5%
The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.
ROE (return on equity) by year and by quarter
| Fiscal year | Period ending | ROE (return on equity) | Net income | Shareholders' equity |
|---|---|---|---|---|
| Today | 39.48% | 9.24B | 23.40B | |
| FY2025 | 31 Dec 2025 | 38.19% | 7.06B | 18.47B |
| FY2024 | 31 Dec 2024 | -54.69% | -8.93B | 16.34B |
| FY2023 | 31 Dec 2023 | 27.32% | 8.04B | 29.43B |
| FY2022 | 31 Dec 2022 | 20.43% | 6.35B | 31.06B |
| FY2021 | 31 Dec 2021 | 19.51% | 7.01B | 35.95B |
| FY2020 | 31 Dec 2020 | -23.78% | -9.00B | 37.82B |
| FY2019 | 31 Dec 2019 | 6.71% | 3.46B | 51.60B |
| FY2018 | 31 Dec 2018 | 35.26% | 4.95B | 14.03B |
| FY2017 | 31 Dec 2017 | 8.30% | 975.00M | 11.74B |
| FY2016 | 31 Dec 2016 | 27.86% | 4.51B | 16.18B |
| FY2015 | 31 Dec 2015 | 11.43% | 1.63B | 14.27B |
| FY2014 | 31 Dec 2014 | 13.66% | 2.03B | 14.85B |
| FY2013 | 31 Dec 2013 | 17.03% | 2.58B | 15.15B |
| FY2012 | 31 Dec 2012 | 18.36% | 2.50B | 13.62B |
| FY2011 | 31 Dec 2011 | 32.97% | 5.26B | 15.96B |
| FY2010 | 31 Dec 2010 | 28.72% | 4.51B | 15.71B |
| FY2009 | 31 Dec 2009 | 79.92% | 11.86B | 14.84B |
| FY2008 | 31 Dec 2008 | 51.00% | 6.24B | 12.24B |
| FY2007 | 31 Dec 2007 | 20.50% | 2.17B | 10.56B |
| FY2006 | 31 Dec 2006 | 15.86% | 1.59B | 9.99B |
| FY2005 | 31 Dec 2005 | 26.77% | 3.00B | 11.21B |
| FY2004 | 31 Dec 2004 | 23.41% | 2.39B | 10.20B |
| FY2003 | 31 Dec 2003 | 31.74% | 3.11B | 9.79B |
| FY2002 | 31 Dec 2002 | 24.41% | 2.14B | 8.76B |
| FY2001 | 31 Dec 2001 | 53.27% | 4.83B | 9.08B |
| FY2000 | 31 Dec 2000 | 51.32% | 4.71B | 9.18B |
| FY1999 | 31 Dec 1999 | 48.20% | 4.17B | 8.65B |
| FY1998 | 31 Dec 1998 | 41.46% | 3.14B | 7.58B |
| FY1997 | 31 Dec 1997 | 44.40% | 3.21B | 7.22B |
| FY1996 | 31 Dec 1996 | 43.38% | 2.85B | 6.57B |
| FY1995 | 31 Dec 1995 | 31.12% | 1.81B | 5.82B |
| FY1994 | 31 Dec 1994 | 32.29% | 1.84B | 5.70B |
| FY1993 | 31 Dec 1993 | 32.98% | 1.96B | 5.94B |
| FY1992 | 31 Dec 1992 | 26.63% | 1.60B | 6.02B |
| FY1991 | 31 Dec 1991 | 35.48% | 2.06B | 5.80B |
| FY1990 | 31 Dec 1990 | 32.26% | 1.75B | 5.42B |
| FY1989 | 31 Dec 1989 | 14.69% | 747.00M | 5.08B |
| FY1988 | 31 Dec 1988 | 25.34% | 1.25B | 4.95B |
| FY1987 | 31 Dec 1987 | 22.46% | 1.07B | 4.76B |
| Quarter | Period ending | ROE (return on equity) | Net income | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 39.48% | 9.24B | 23.40B |
| Q2 FY2026 | 30 Jun 2026 | 41.55% | 9.27B | 22.32B |
| Q1 FY2026 | 31 Mar 2026 | 36.23% | 7.27B | 20.07B |
| Q4 FY2025 | 31 Dec 2025 | 38.19% | 7.06B | 18.47B |
| Q3 FY2025 | 30 Sept 2025 | 32.59% | 6.05B | 18.55B |
| Q2 FY2025 | 30 Jun 2025 | 29.06% | 5.07B | 17.44B |
| Q1 FY2025 | 31 Mar 2025 | 31.27% | 5.44B | 17.39B |
| Q4 FY2024 | 31 Dec 2024 | -54.69% | -8.93B | 16.34B |
| Q3 FY2024 | 30 Sept 2024 | -42.28% | -7.25B | 17.14B |
| Q2 FY2024 | 30 Jun 2024 | -38.37% | -6.53B | 17.02B |
| Q1 FY2024 | 31 Mar 2024 | -37.20% | -6.14B | 16.49B |
| Q4 FY2023 | 31 Dec 2023 | 27.32% | 8.04B | 29.43B |
| Q3 FY2023 | 30 Sept 2023 | 28.63% | 8.30B | 29.00B |
| Q2 FY2023 | 30 Jun 2023 | 24.95% | 7.98B | 31.97B |
| Q1 FY2023 | 31 Mar 2023 | 23.03% | 7.33B | 31.82B |
| Q4 FY2022 | 31 Dec 2022 | 20.43% | 6.35B | 31.06B |
| Q3 FY2022 | 30 Sept 2022 | 20.48% | 6.69B | 32.67B |
| Q2 FY2022 | 30 Jun 2022 | 20.36% | 6.64B | 32.60B |
| Q1 FY2022 | 31 Mar 2022 | 19.85% | 6.27B | 31.58B |
| Q4 FY2021 | 31 Dec 2021 | 19.51% | 7.01B | 35.95B |
| Q3 FY2021 | 30 Sept 2021 | -14.47% | -5.39B | 37.21B |
| Q2 FY2021 | 30 Jun 2021 | -13.74% | -5.06B | 36.81B |
| Q1 FY2021 | 31 Mar 2021 | -16.49% | -6.20B | 37.61B |
| Q4 FY2020 | 31 Dec 2020 | -23.78% | -9.00B | 37.82B |
| Q3 FY2020 | 30 Sept 2020 | -0.06% | -28.00M | 50.16B |
| Q2 FY2020 | 30 Jun 2020 | -1.10% | -540.00M | 49.09B |
| Q1 FY2020 | 31 Mar 2020 | 1.96% | 979.00M | 49.91B |
| Q4 FY2019 | 31 Dec 2019 | 6.71% | 3.46B | 51.60B |
| Q3 FY2019 | 30 Sept 2019 | 32.17% | 5.68B | 17.65B |
| Q2 FY2019 | 30 Jun 2019 | 38.78% | 6.22B | 16.05B |
| Q1 FY2019 | 31 Mar 2019 | 33.95% | 5.17B | 15.22B |
| Q4 FY2018 | 31 Dec 2018 | 35.26% | 4.95B | 14.03B |
| Q3 FY2018 | 30 Sept 2018 | 10.70% | 1.46B | 13.64B |
| Q2 FY2018 | 30 Jun 2018 | 3.28% | 404.00M | 12.32B |
| Q1 FY2018 | 31 Mar 2018 | 7.38% | 944.00M | 12.79B |
| Q4 FY2017 | 31 Dec 2017 | 8.30% | 975.00M | 11.74B |
| Q3 FY2017 | 30 Sept 2017 | 28.42% | 4.20B | 14.78B |
| Q2 FY2017 | 30 Jun 2017 | 31.03% | 4.56B | 14.70B |
| Q1 FY2017 | 31 Mar 2017 | 33.48% | 4.83B | 14.42B |
| Q4 FY2016 | 31 Dec 2016 | 27.86% | 4.51B | 16.18B |
| Q3 FY2016 | 30 Sept 2016 | 21.91% | 3.42B | 15.61B |
| Q2 FY2016 | 30 Jun 2016 | 19.68% | 2.94B | 14.92B |
| Q1 FY2016 | 31 Mar 2016 | 11.39% | 1.64B | 14.39B |
| Q4 FY2015 | 31 Dec 2015 | 11.43% | 1.63B | 14.27B |
| Q3 FY2015 | 30 Sept 2015 | 12.24% | 1.85B | 15.08B |
| Q2 FY2015 | 30 Jun 2015 | 12.22% | 1.85B | 15.12B |
| Q1 FY2015 | 31 Mar 2015 | 14.74% | 2.29B | 15.55B |
| Q4 FY2014 | 31 Dec 2014 | 13.66% | 2.03B | 14.85B |
| Q3 FY2014 | 30 Sept 2014 | 18.07% | 2.74B | 15.14B |
| Q2 FY2014 | 30 Jun 2014 | 17.60% | 2.70B | 15.33B |
| Q1 FY2014 | 31 Mar 2014 | 18.70% | 2.89B | 15.47B |
| Q4 FY2013 | 31 Dec 2013 | 17.03% | 2.58B | 15.15B |
| Q3 FY2013 | 30 Sept 2013 | 18.80% | 2.77B | 14.73B |
| Q2 FY2013 | 30 Jun 2013 | 9.49% | 1.36B | 14.37B |
| Q1 FY2013 | 31 Mar 2013 | 12.02% | 1.64B | 13.66B |
| Q4 FY2012 | 31 Dec 2012 | 18.36% | 2.50B | 13.62B |
| Q3 FY2012 | 30 Sept 2012 | 20.20% | 2.81B | 13.90B |
| Q2 FY2012 | 30 Jun 2012 | 30.29% | 4.88B | 16.10B |
| Q1 FY2012 | 31 Mar 2012 | 32.90% | 5.38B | 16.34B |
| Q4 FY2011 | 31 Dec 2011 | 32.97% | 5.26B | 15.96B |
| Q3 FY2011 | 30 Sept 2011 | 29.39% | 4.87B | 16.57B |
| Q2 FY2011 | 30 Jun 2011 | 29.46% | 4.82B | 16.35B |
| Q1 FY2011 | 31 Mar 2011 | 29.87% | 4.78B | 16.00B |
| Q4 FY2010 | 31 Dec 2010 | 28.72% | 4.51B | 15.71B |
| Q3 FY2010 | 30 Sept 2010 | 75.29% | 12.02B | 15.97B |
| Q2 FY2010 | 30 Jun 2010 | 76.67% | 12.01B | 15.67B |
| Q1 FY2010 | 31 Mar 2010 | 78.97% | 12.04B | 15.25B |
| Q4 FY2009 | 31 Dec 2009 | 79.92% | 11.86B | 14.84B |
| Q3 FY2009 | 30 Sept 2009 | 32.74% | 4.75B | 14.52B |
| Q2 FY2009 | 30 Jun 2009 | 39.51% | 5.57B | 14.10B |
| Q1 FY2009 | 31 Mar 2009 | 39.57% | 5.28B | 13.34B |
| Q4 FY2008 | 31 Dec 2008 | 42.86% | 5.25B | 12.24B |
| Q3 FY2008 | 30 Sept 2008 | 30.25% | 3.91B | 12.94B |
| Q2 FY2008 | 30 Jun 2008 | 24.73% | 2.67B | 10.78B |
| Q1 FY2008 | 31 Mar 2008 | 22.40% | 2.37B | 10.56B |
| Q4 FY2007 | 31 Dec 2007 | 20.50% | 2.17B | 10.56B |
| Q3 FY2007 | 30 Sept 2007 | 19.01% | 2.12B | 11.15B |
| Q2 FY2007 | 30 Jun 2007 | 14.87% | 1.60B | 10.76B |
| Q1 FY2007 | 31 Mar 2007 | 15.21% | 1.56B | 10.26B |
| Q4 FY2006 | 31 Dec 2006 | 15.86% | 1.59B | 9.99B |
| Q3 FY2006 | 30 Sept 2006 | 19.14% | 2.22B | 11.59B |
| Q2 FY2006 | 30 Jun 2006 | 24.28% | 2.84B | 11.71B |
| Q1 FY2006 | 31 Mar 2006 | 27.53% | 3.18B | 11.56B |
| Q4 FY2005 | 31 Dec 2005 | 26.77% | 3.00B | 11.21B |
| Q3 FY2005 | 30 Sept 2005 | 23.43% | 2.64B | 11.27B |
| Q2 FY2005 | 30 Jun 2005 | 22.53% | 2.43B | 10.80B |
| Q1 FY2005 | 31 Mar 2005 | 18.85% | 1.96B | 10.38B |
| Q4 FY2004 | 31 Dec 2004 | 23.41% | 2.39B | 10.20B |
| Q3 FY2004 | 30 Sept 2004 | 26.56% | 2.83B | 10.66B |
| Q2 FY2004 | 30 Jun 2004 | 28.57% | 2.98B | 10.43B |
| Q1 FY2004 | 31 Mar 2004 | 31.85% | 3.36B | 10.53B |
| Q4 FY2003 | 31 Dec 2003 | 32.53% | 3.18B | 9.79B |
| Q3 FY2003 | 30 Sept 2003 | 29.55% | 2.97B | 10.07B |
| Q2 FY2003 | 30 Jun 2003 | 25.22% | 2.43B | 9.61B |
| Q1 FY2003 | 31 Mar 2003 | 21.53% | 2.00B | 9.30B |
| Q4 FY2002 | 31 Dec 2002 | 23.60% | 2.07B | 8.76B |
| Q3 FY2002 | 30 Sept 2002 | 34.31% | 3.16B | 9.20B |
| Q2 FY2002 | 30 Jun 2002 | 35.57% | 3.81B | 10.71B |
| Q1 FY2002 | 31 Mar 2002 | 42.23% | 4.53B | 10.73B |
| Q4 FY2001 | 31 Dec 2001 | 55.24% | 5.01B | 9.08B |
| Q3 FY2001 | 30 Sept 2001 | 47.44% | 4.71B | 9.94B |
| Q2 FY2001 | 30 Jun 2001 | 51.75% | 4.94B | 9.54B |
| Q1 FY2001 | 31 Mar 2001 | 51.11% | 4.83B | 9.44B |
| Q4 FY2000 | 31 Dec 2000 | 51.32% | 4.71B | 9.18B |
| Q3 FY2000 | 30 Sept 2000 | 50.24% | 4.60B | 9.16B |
| Q2 FY2000 | 30 Jun 2000 | 50.02% | 4.46B | 8.92B |
| Q1 FY2000 | 31 Mar 2000 | 49.06% | 4.32B | 8.81B |
| Q4 FY1999 | 31 Dec 1999 | 48.20% | 4.17B | 8.65B |
| Q3 FY1999 | 30 Sept 1999 | 47.66% | 4.02B | 8.44B |
| Q2 FY1999 | 30 Jun 1999 | 48.30% | 3.89B | 8.06B |
| Q1 FY1999 | 31 Mar 1999 | 48.71% | 3.78B | 7.75B |
| Q4 FY1998 | 31 Dec 1998 | 47.99% | 3.64B | 7.58B |
| Q3 FY1998 | 30 Sept 1998 | 46.77% | 3.53B | 7.55B |
| Q2 FY1998 | 30 Jun 1998 | 47.20% | 3.42B | 7.24B |
| Q1 FY1998 | 31 Mar 1998 | 46.24% | 3.32B | 7.19B |
| Q4 FY1997 | 31 Dec 1997 | 44.40% | 3.21B | 7.22B |
| Q3 FY1997 | 30 Sept 1997 | 45.03% | 3.12B | 6.93B |
| Q2 FY1997 | 30 Jun 1997 | 44.26% | 3.02B | 6.82B |
| Q1 FY1997 | 31 Mar 1997 | 43.40% | 2.93B | 6.76B |
| Q4 FY1996 | 31 Dec 1996 | 43.38% | 2.85B | 6.57B |
| Q3 FY1996 | 30 Sept 1996 | 31.38% | 1.99B | 6.35B |
| Q2 FY1996 | 30 Jun 1996 | 31.81% | 1.93B | 6.07B |
| Q1 FY1996 | 31 Mar 1996 | 31.69% | 1.88B | 5.94B |
| Q4 FY1995 | 31 Dec 1995 | 31.12% | 1.81B | 5.82B |
| Q3 FY1995 | 30 Sept 1995 | 32.48% | 2.05B | 6.32B |
| Q2 FY1995 | 30 Jun 1995 | 31.93% | 1.98B | 6.21B |
| Q1 FY1995 | 31 Mar 1995 | 32.19% | 1.92B | 5.96B |
| Q4 FY1994 | 31 Dec 1994 | 32.29% | 1.84B | 5.70B |
| Q3 FY1994 | 30 Sept 1994 | 32.46% | 2.00B | 6.16B |
| Q2 FY1994 | 30 Jun 1994 | 33.28% | 1.99B | 5.97B |
| Q1 FY1994 | 31 Mar 1994 | 32.76% | 1.97B | 6.00B |
| Q4 FY1993 | 31 Dec 1993 | 32.98% | 1.96B | 5.94B |
| Q3 FY1993 | 30 Sept 1993 | 26.90% | 1.68B | 6.25B |
| Q2 FY1993 | 30 Jun 1993 | 26.80% | 1.66B | 6.20B |
| Q1 FY1993 | 31 Mar 1993 | 26.57% | 1.63B | 6.14B |
| Q4 FY1992 | 31 Dec 1992 | 26.63% | 1.60B | 6.02B |
| Q3 FY1992 | 30 Sept 1992 | 34.57% | 2.14B | 6.18B |
| Q2 FY1992 | 30 Jun 1992 | 35.55% | 2.11B | 5.94B |
| Q1 FY1992 | 31 Mar 1992 | 36.18% | 2.11B | 5.83B |
| Q4 FY1991 | 31 Dec 1991 | 35.48% | 2.06B | 5.80B |
| Q3 FY1991 | 30 Sept 1991 | 34.63% | 1.97B | 5.69B |
| Q2 FY1991 | 30 Jun 1991 | 34.97% | 1.90B | 5.45B |
| Q1 FY1991 | 31 Mar 1991 | 34.03% | 1.83B | 5.38B |
| Q4 FY1990 | 31 Dec 1990 | 32.26% | 1.75B | 5.42B |
| Q3 FY1990 | 30 Sept 1990 | 18.03% | 969.00M | 5.38B |
| Q2 FY1990 | 30 Jun 1990 | 16.74% | 884.00M | 5.28B |
| Q1 FY1990 | 31 Mar 1990 | 15.63% | 812.00M | 5.20B |
| Q4 FY1989 | 31 Dec 1989 | 14.69% | 747.00M | 5.08B |
| Q3 FY1989 | 30 Sept 1989 | — | 1.39B | — |
| Q2 FY1989 | 30 Jun 1989 | — | 1.34B | — |
| Q1 FY1989 | 31 Mar 1989 | — | 1.30B | — |
| Q4 FY1988 | 31 Dec 1988 | 25.34% | 1.25B | 4.95B |
| Q3 FY1988 | 30 Sept 1988 | — | 1.23B | — |
| Q2 FY1988 | 30 Jun 1988 | — | 1.14B | — |
| Q1 FY1988 | 31 Mar 1988 | — | 1.10B | — |
| Q4 FY1987 | 31 Dec 1987 | 22.46% | 1.07B | 4.76B |
| Q3 FY1987 | 30 Sept 1987 | — | — | — |
| Q2 FY1987 | 30 Jun 1987 | — | — | — |
| Q1 FY1987 | 31 Mar 1987 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios
Common questions about Bristol-Myers Squibb's ROE
Source: Financial Modeling PrepVerified against SEC filings
